Member Info for Livedataaccount

Must be over soon?

Come on guys. Can we get back on topic.

What's AS going to announce when the 40 days are up? Another new strategy, perhaps? Phase 1c?

When is this 40 day blackout over? Since the CEO has brought it up on camera I am now expecting him to release some important news or at least ast some discussion?

Otherwise ise he is on record using it as an excuse

Imagine the irony. An lft

Honestly, I've never read so much nonsense as I see on here

Notrex, how about renaming him to Elon?

Perhaps that will bring some positivity?

Sometimes I wonder why I bother with this forum

1509

Its all good. One day avacta will be worth billions

I think the the acquisitions were probably just about profitable but combined with Avacta Dx division it's negative. All in all a complete snafu and terrible management when you need funding for tx

That's harsh. And probably not the case.

Spot on nano. AS was very silly to spend all that money on dx.

Will it ever return to its former glory?. Jus wondering whether to cash in and buy gaf in Monaco.

It was silly to spend all that money on the dx companies

What good will spinning off dx do for Avacta therapeutics or the cash position?

I imagine avacta are sounding out potential buyers for dx. Unfortunately it's currently loss making

Avacta are a loss making company. I doubt they will use their cash pile to pay off the loan. They will just issue equity. Diluting the company matters less to the bod than it does to us annoying retail investors.

What exactly can't they talk about?

They have explained that timescales

Maybe a new drug for the pipeline

Cant see that adding any value right now.

They still haven't done the Ind for ava3996

Agree code junkie.

I am sure there are certain aspects that can't be discussed due to the 40 day blackout but think it's being used as an excuse.

Anyway it's quite clear there has been a snafu in the strategy and it's damaged Avacta's shareprice significantly.

Whilst the CEO spoke well I don't have a great deal of faith in timelines or lip service and new pipelines etc.

I just watched the webinar. AS came across very well amd if anything a little subdued. He answered the questions very well.

Probably a little beaten after the recent raise.

I hope he follows through with his comments about new pipeline indications.

From the lead investigator udai banerji

https://twitter.com/udai_banerji/status/1777778199289581619?t=u0_DefL5qteic1VCeQk6pg&s=19

New frontiers in exploiting stroma for therapy. FAP directed precision medicine. Phase I of AVA600 showing tolerability, plasmas/tumour PK and clinical proof of concept response in FAP high tumours. Abstract CT188 #AACR2024 @ICR_London @royalmarsdenNHS @ECMC_UK

What is he going to talk about in today's webinar?

CC has just given a very detailed overview of the trial.